Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.

Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Abstract Text:

    geoffrey k aguirreGeoffrey K Aguirre, ,artur v cideciyanArtur V Cideciyan,david h brainardDavid H Brainard,tomas s alemanTomas S Aleman,alejandro j romanAlejandro J Roman,brian b avantsBrian B Avants,james c geeJames C Gee,marc korczykowskiMarc Korczykowski,william w hauswirthWilliam W Hauswirth,gregory m aclandGregory M Acland,gustavo d aguirreGustavo D Aguirre,samuel g jacobsonSamuel G Jacobson,geoffrey k aguirreGeoffrey K Aguirre, ,artur v cideciyanArtur V Cideciyan,david h brainardDavid H Brainard,tomas s alemanTomas S Aleman,alejandro j romanAlejandro J Roman,brian b avantsBrian B Avants,james c geeJames C Gee,marc korczykowskiMarc Korczykowski,william w hauswirthWilliam W Hauswirth,gregory m aclandGregory M Acland,gustavo d aguirreGustavo D Aguirre,samuel g jacobsonSamuel G Jacobson,

    BACKGROUND: RPE65 is an essential molecule in the retinoid-visual cycle, and RPE65 gene mutations cause the congenital human blindness known as Leber congenital amaurosis (LCA). Somatic gene therapy delivered to the retina of blind dogs with an RPE65 mutation dramatically restores retinal physiology and has sparked international interest in human treatment trials for this incurable disease. An unanswered question is how the visual cortex responds after prolonged sensory deprivation from retinal dysfunction. We therefore studied the cortex of RPE65-mutant dogs before and after retinal gene therapy. Then, we inquired whether there is visual pathway integrity and responsivity in adult humans with LCA due to RPE65 mutations (RPE65-LCA). METHODS AND FINDINGS: RPE65-mutant dogs were studied with fMRI. Prior to therapy, retinal and subcortical responses to light were markedly diminished, and there were minimal cortical responses within the primary visual areas of the lateral gyrus (activation amplitude mean +/- standard deviation [SD] = 0.07% +/- 0.06% and volume = 1.3 +/- 0.6 cm(3)). Following therapy, retinal and subcortical response restoration was accompanied by increased amplitude (0.18% +/- 0.06%) and volume (8.2 +/- 0.8 cm(3)) of activation within the lateral gyrus (p < 0.005 for both). Cortical recovery occurred rapidly (within a month of treatment) and was persistent (as long as 2.5 y after treatment). Recovery was present even when treatment was provided as late as 1-4 y of age. Human RPE65-LCA patients (ages 18-23 y) were studied with structural magnetic resonance imaging. Optic nerve diameter (3.2 +/- 0.5 mm) was within the normal range (3.2 +/- 0.3 mm), and occipital cortical white matter density as judged by voxel-based morphometry was slightly but significantly altered (1.3 SD below control average, p = 0.005). Functional magnetic resonance imaging in human RPE65-LCA patients revealed cortical responses with a markedly diminished activation volume (8.8 +/- 1.2 cm(3)) compared to controls (29.7 +/- 8.3 cm(3), p < 0.001) when stimulated with lower intensity light. Unexpectedly, cortical response volume (41.2 +/- 11.1 cm(3)) was comparable to normal (48.8 +/- 3.1 cm(3), p = 0.2) with higher intensity light stimulation. CONCLUSIONS: Visual cortical responses dramatically improve after retinal gene therapy in the canine model of RPE65-LCA. Human RPE65-LCA patients have preserved visual pathway anatomy and detectable cortical activation despite limited visual experience. Taken together, the results support the potential for human visual benefit from retinal therapies currently being aimed at restoring vision to the congenitally blind with genetic retinal disease.

    Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Publishing Authors By Initials

    gk aguirreGK Aguirre,am AM ,av cideciyanAV Cideciyan,dh brainardDH Brainard,ts alemanTS Aleman,aj romanAJ Roman,bb avantsBB Avants,jc geeJC Gee,m korczykowskiM Korczykowski,ww hauswirthWW Hauswirth,gm aclandGM Acland,gd aguirreGD Aguirre,sg jacobsonSG Jacobson,gk aguirreGK Aguirre,am AM ,av cideciyanAV Cideciyan,dh brainardDH Brainard,ts alemanTS Aleman,aj romanAJ Roman,bb avantsBB Avants,jc geeJC Gee,m korczykowskiM Korczykowski,ww hauswirthWW Hauswirth,gm aclandGM Acland,gd aguirreGD Aguirre,sg jacobsonSG Jacobson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: PLoS medicine

    VOLUME: 4

    Page Numbers: e230

    Journal Abbreviation: PLoS Med.

    ISSN: 1549-1676

    DAY: 9

    MONTH: Jun

    YEAR: 2007

    Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101231360

    Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.

    AFFILIATION: Department of Neurology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. aguirreg@mail.med.upenn.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NINDS

    GRANT: P30 NS045839

    ACRONYM: NS

    MEDLINETA: PLoS Med

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News